In vitro analysis of replicative capacity and phenotypic susceptibility of integrase mutant HIV-2 viruses

被引：0
|
作者：
Le Hingrat, Q. [1 ]
Collin, G. [1 ]
Damond, F. [1 ]
Peytavin, G. [2 ]
Lebourgeois, S. [1 ]
Ghosn, J. [3 ]
Bachelard, A. [3 ]
Ferre, V. [1 ]
Matheron, S. [3 ]
Descamps, D. [1 ]
Charpentier, C. [1 ]
机构：
[1] Hop Bichat Claude Bernard, AP HP, Lab Virol, Paris, France
[2] Hop Bichat Claude Bernard, AP HP, Lab Pharmacol, Paris, France
[3] Hop Bichat Claude Bernard, AP HP, Serv Malad Infect & Trop, Paris, France
来源：
HIV MEDICINE | 2019年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
E13/27
引用
收藏
页码：173 / 173
页数：1
相关论文
共 50 条
  • [11] Mutation N155H in HIV-2 integrase confers high phenotypic resistance to raltegravir and impairs replication capacity
    Salgado, Maria
    Toro, Carlos
    Simon, Ainhoa
    Garrido, Carolina
    Blanco, Francisco
    Soriano, Vincent
    Rodes, Berta
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 (02) : 173 - 175
  • [12] Replication capacity and drug susceptibility of lopinavir-resistant HIV-2
    Mo, H.
    Lu, X.
    Masse, S.
    Dekhtyar, T.
    Lu, L.
    Mondal, R.
    Koev, G.
    Ng, T.
    Bernstein, B.
    Gao, F.
    Molla, A.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S49 - S49
  • [13] Phenotypic susceptibility of HIV-2 to raltegravir: integrase mutations Q148R and N155H confer raltegravir resistance
    Smith, Robert A.
    Raugi, Dana N.
    Kiviat, Nancy B.
    Hawes, Stephen E.
    Mullins, James I.
    Sow, Papa S.
    Gottlieb, Geoffrey S.
    AIDS, 2011, 25 (18) : 2235 - 2241
  • [14] HIV-2 Integrase Polymorphisms and Longitudinal Genotypic Analysis of HIV-2 Infected Patients Failing a Raltegravir-Containing Regimen
    Cavaco-Silva, Joana
    Abecasis, Ana
    Miranda, Ana Claudia
    Pocas, Jose
    Narciso, Jorge
    Aguas, Maria Joao
    Maltez, Fernando
    Almeida, Isabel
    Germano, Isabel
    Diniz, Antonio
    de Fatima Goncalves, Maria
    Gomes, Perpetua
    Cunha, Celso
    Camacho, Ricardo Jorge
    PLOS ONE, 2014, 9 (03):
  • [15] REPLICATIVE AND CYTOPATHIC CHARACTERISTICS OF HIV-2 AND SEVERITY OF INFECTION
    ALBERT, J
    BOTTIGER, B
    BIBERFELD, G
    FENYO, EM
    LANCET, 1989, 1 (8642): : 852 - 853
  • [16] Phenotypic assays of 5 integrase inhibitors on HIV-2 clinical isolates reveal a new resistance pathway
    Le Hingrat, Q.
    Collin, G.
    Peytavin, G.
    Visseaux, B.
    Bertine, M.
    Tubiana, R.
    Karmochkine, M.
    Valin, N.
    Lemaignen, A.
    Bernard, L.
    Damond, F.
    Matheron, S.
    Descamps, D.
    Charpentier, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21 : 138 - 139
  • [17] Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir
    Danielle Perez-Bercoff
    Perrine Triqueneaux
    Christine Lambert
    Aboubacar Alassane Oumar
    Anne-Marie Ternes
    Sounkalo Dao
    Patrick Goubau
    Jean-Claude Schmit
    Jean Ruelle
    Retrovirology, 7
  • [18] Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir
    Bercoff, Danielle Perez
    Triqueneaux, Perrine
    Lambert, Christine
    Oumar, Aboubacar Alassane
    Ternes, Anne-Marie
    Dao, Sounkalo
    Goubau, Patrick
    Schmit, Jean-Claude
    Ruelle, Jean
    RETROVIROLOGY, 2010, 7
  • [19] Selection and analysis of HIV-1 integrase strand transfer inhibitor resistant mutant viruses
    Witmer, Marc
    Danovich, Robert
    METHODS, 2009, 47 (04) : 277 - 282
  • [20] Development of a phenotypic susceptibility assay for HIV-1 integrase inhibitors
    Heger, Eva
    Theis, Alexandra Andree
    Remmel, Klaus
    Walter, Hauke
    Pironti, Alejandro
    Knops, Elena
    Di Cristanziano, Veronica
    Jensen, Bjoern
    Esser, Stefan
    Kaiser, Rolf
    Luebke, Nadine
    JOURNAL OF VIROLOGICAL METHODS, 2016, 238 : 29 - 37
12345